When your submission is received you will be notified.
Submission Instructions for your Research Grant Application
The Southeastern Society of Plastic and Reconstructive Surgeons is required by the IRS to document the appropriate disbursement of funds as well as maintain progress reports on the funded programs. To assure that we meet this obligation, award recipients are required to provide a written progress report six months into the funding period. Half of the award amount will be distributed at the beginning of the funding period, with the remainder being distributed following receipt and approval of the six month progress report. It is the responsibility of the research grant award winner to do all the communication with the Southeastern Society of Plastic and Reconstructive Surgeons Research Grant Committee, not the sub-investigators or the research assistants. Failure to comply can only be interpreted by the Society as the failure to carry out the research and purposes which had been the basis for the grant itself. In an instance where an awardee fails to file a progress report in a timely manner, the SESPRS will be compelled to report to the appropriate federal and state tax authorities about the likelihood of inappropriate use of grant funds. Such failure to report shall also, of course, operate adversely with respect to any future grants to that institution or practice.
Once the award has been granted, the award recipient must contact the Society's offices if for any reason the protocol has changed. The notification must take place before research is to begin under the new protocol.
Award recipients must present their findings at the 2020 SESPRS Annual Meeting. The final progress report should list publications resulting from your study, as well as additional grant proposals you have submitted or support you have received because of this research funding.
Occasionally, the SESPRS will require information on subsequent grants, papers and presentations. All grant recipients must respond to these requests. As in all cases of funding, it is necessary to acknowledge SESPRS grant support in any oral or written papers.
Please use the following official grant application
To facilitate your completion of this form and ensure success, the Research Grant Committee offers the following suggestions:
Purpose: A statement on the clinical relevance of the project is extremely important for this grant application.
Background: A concise summary of previous work. State your understanding of the available knowledge pertaining to the subject. Include your critical analysis of past deficiencies. If you have preliminary data of your own, include it here.
Methods:
We want to know exactly how you are going to do the project. Approval must be received by the Human Assurance Committee or other regulatory committees from the appropriate institution.
Budget: Investigators will be funded up to $15,000 by the SESPRS. The SESPRS does not pay for indirect or administrative costs. Payment will be made in two installments. The initial installment of one-half of the funded amount will be made upon selection following receipt by SESPRS of a signed acceptance form. The recipient will be required to submit a written progress report six months after the initial grant payment. Upon review of that report and determination by SESPRS that the grant is progressing appropriately, the second installment payment will be paid. You may submit more than one application for consideration. If two grants during the cycle are available for award, a limit has been set for only one award per investigator.
Human or Animal Research Approval:
It is your responsibility to submit the grant application for review by your animal utilization or human subjects review committee for experimental work and to ensure it complies with the institution's regulations. All projects must receive prior approval. Please include letter of approval of human or animal protocol.
NOTE:
If your address or other pertinent data changes after receiving a grant, be certain to notify the SESPRS Society office at 435-901-2544 
